Duration of Dialysis in Acute Kidney Injury Donors and Transplant Outcomes.


Journal

Journal of the American College of Surgeons
ISSN: 1879-1190
Titre abrégé: J Am Coll Surg
Pays: United States
ID NLM: 9431305

Informations de publication

Date de publication:
23 Oct 2023
Historique:
medline: 23 10 2023
pubmed: 23 10 2023
entrez: 23 10 2023
Statut: aheadofprint

Résumé

Acute kidney injury (AKI) kidneys, including those from donors on dialysis, are often underutilized, although there is increasing data available demonstrating good transplant outcomes. To date, data on the duration of donor dialysis and transplant outcomes are limited. This was a single-center study of deceased donor kidney transplants (DDKT) from 2010 to 2022. The study cohort consisted of recipients of DDKT from donors with AKI and on dialysis. Three groups were identified based on the predetermined interquartile range of donor dialysis duration: a) 1-2 dialysis days, b) 3-4 dialysis days, and c) ≥5 dialysis days. During this period, 765 AKI DDKT were performed, of which 230 were from donors on dialysis. The median dialysis duration was two days with a maximum of 13 days. Across the three groups, there were no differences in recipient age (p=0.23) or dialysis vintage (p=0.70). Donor age (p=0.86) and KDPI (p=0.57) were comparable between the groups. DDKT from donors on dialysis ≥5 days had lower terminal creatinine levels (p=0.003) and longer cold ischemia times (p=0.04). Post-transplant, the median length of hospital stay was 3 days for all groups (p=0.75). There were no differences in delayed graft function occurrence (94.4% vs. 86.8% vs. 92.1%, p=0.19), duration of DGF (p=0.56) or readmissions (p=0.99). At one-year, the estimated glomerular filtration rate (p=0.76), patient survival (p=0.82), or death-censored graft survival (p=0.28) were comparable. Excellent outcomes have been observed in AKI DDKT, including those coming from donors on dialysis. In this small cohort, the duration of donor dialysis did not adversely affect outcomes. Cautious expansion of the donor pool, including donors on dialysis, should be considered given the ongoing organ shortage.

Sections du résumé

BACKGROUND BACKGROUND
Acute kidney injury (AKI) kidneys, including those from donors on dialysis, are often underutilized, although there is increasing data available demonstrating good transplant outcomes. To date, data on the duration of donor dialysis and transplant outcomes are limited.
STUDY DESIGN METHODS
This was a single-center study of deceased donor kidney transplants (DDKT) from 2010 to 2022. The study cohort consisted of recipients of DDKT from donors with AKI and on dialysis. Three groups were identified based on the predetermined interquartile range of donor dialysis duration: a) 1-2 dialysis days, b) 3-4 dialysis days, and c) ≥5 dialysis days.
RESULTS RESULTS
During this period, 765 AKI DDKT were performed, of which 230 were from donors on dialysis. The median dialysis duration was two days with a maximum of 13 days. Across the three groups, there were no differences in recipient age (p=0.23) or dialysis vintage (p=0.70). Donor age (p=0.86) and KDPI (p=0.57) were comparable between the groups. DDKT from donors on dialysis ≥5 days had lower terminal creatinine levels (p=0.003) and longer cold ischemia times (p=0.04). Post-transplant, the median length of hospital stay was 3 days for all groups (p=0.75). There were no differences in delayed graft function occurrence (94.4% vs. 86.8% vs. 92.1%, p=0.19), duration of DGF (p=0.56) or readmissions (p=0.99). At one-year, the estimated glomerular filtration rate (p=0.76), patient survival (p=0.82), or death-censored graft survival (p=0.28) were comparable.
CONCLUSIONS CONCLUSIONS
Excellent outcomes have been observed in AKI DDKT, including those coming from donors on dialysis. In this small cohort, the duration of donor dialysis did not adversely affect outcomes. Cautious expansion of the donor pool, including donors on dialysis, should be considered given the ongoing organ shortage.

Identifiants

pubmed: 37870238
doi: 10.1097/XCS.0000000000000870
pii: 00019464-990000000-00743
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2023 by the American College of Surgeons. Published by Wolters Kluwer Health, Inc. All rights reserved.

Auteurs

Rachana Punukollu (R)

Division of Transplant Surgery, Department of Surgery, Mayo Clinic, Phoenix, AZ.

Stephanie Ohara (S)

Division of Surgery, Valleywise Health Medical Center, Creighton University, Phoenix, AZ.

Pooja Budhiraja (P)

Division of Nephrology, Mayo Clinic, Phoenix, AZ.

Maxwell L Smith (ML)

Division of Anatomic Pathology, Mayo Clinic, Phoenix, AZ.

Kayla Kumm (K)

Division of Transplant Surgery, Department of Surgery, Mayo Clinic, Phoenix, AZ.

Brianna Ruch (B)

Division of Transplant Surgery, Department of Surgery, Mayo Clinic, Phoenix, AZ.

Suman Misra (S)

Division of Nephrology, Mayo Clinic, Phoenix, AZ.

Kunam S Reddy (KS)

Division of Transplant Surgery, Department of Surgery, Mayo Clinic, Phoenix, AZ.

Raymond Heilman (R)

Division of Nephrology, Mayo Clinic, Phoenix, AZ.

Caroline C Jadlowiec (CC)

Division of Transplant Surgery, Department of Surgery, Mayo Clinic, Phoenix, AZ.

Classifications MeSH